Full 1
Welcome to
GCC Oncology Updates Conference Series
Full 1
Full 2
Conference Series
Men's Health Edition
Full 2
Contact Us
CONFERENCE SERIES
Hematology Edition
Contact Us
previous arrow
next arrow

WELCOME

On behalf of the organizing committees, it gives us great pleasure to invite you to the GCC Oncology Updates, designed as a virtual event so all content will be available on the virtual platform.

Immerse yourself in the latest information in the oncology: Hematology Edition, Men’s Health Edition (Prostate & Urology), Women`s Health Edition (Breast & Gynecology), Internal Medicine Edition (Lung, Liver, Gastric & Colorectal).

The scientific program will also feature specialized Oncology Nursing Workshops.
New evidence-based approaches in diagnosis, treatment, clinical and translational research results, innovative techniques, diagnostic tools and risk-assessment strategies will be part of the program. You are Invited!

This is what the new and interactive #GCC-OU series has to offer:

  • Live program for each specialty
  • Parallel session halls with live and on-demand sessions
  • Plenary presentations, challenging cases & workshops
  • Satellite Symposia with updates in Oncology presented by pharmaceutical companies.
  • Live interactive panel discussions.
  • A virtual exhibition hosting top content from the industry partners.
  • All the scientific content to be available on-demand 30 days after each conference, for registered participants.
  • CME Accreditation recognized across all GCC

We look forward to your participation!

AGENDA

Prostate Cancer

Session 1

Chairman Prof. Yasser Farahat

}

1600 - 1605

Welcome Address & Introduction
Yasser Farahat
}

1605 - 1630

Identification of High-Risk Disease and Initial Management of Biochemical Recurrence  
Hassan Jaafar
}

1630 - 1655

Management of mHSPC:  Chemohormonal Therapy and the Evolving Role of Local Therapy in Oligometastatic Disease
Shouki Bazarbashi 
}

1655 - 1720

Manipulating the Androgen Axis: Androgen Biosynthesis Inhibitors and Androgen Receptor Signaling Agents in mHSPC and CRPC  
Abdullah Alsharm
}

1720 - 1745

Recent updates in mCRPC  
Emad Anwar Dawoud
}

1745 - 1815

Satellite Symposium
}

1815 - 1820

Session Closing Remarks  
Yasser Farahat

Session 2

Chairman Dr. Mubarak Al-Mansour

}

1820 - 1825

Welcome Address & Introduction
Mubarak Al-Mansour
}

1825 - 1850

Elevate Care in Advanced Prostate Cancer  
Abdullah Alsharm
}

1850 - 1915

Case-based on CRPC  
Hassan Jaafar
}

1915 - 1945

Updates on prostate cancer management: Why GnRH antagonist?
Bertrand Tombal
}

1945 - 2015

Local experience on PCA
}

2015 - 2100

M0 CRPC: Treatment Options and Goals of Therapy

Case-based Discussion: On Difficult Cases To Treat

 

Case #1: Early M1 CRPC Management (Docetaxel vs. Oral Agents)
Case #2: M1 CRPC Post-docetaxel Chemotherapy and End-of-Life Care (Neuroendocrine)

}

2100 - 2105

Closing remarks
Mubarak Al-Mansour

Urology

Urology Updates

Chairman Dr. Mohannad Alharbi

}

1700 - 1705

Welcome Address & Introduction
Mohannad Alharbi
}

1705 - 1735

Guidelines and Updates for management of Benign Prostatic Hyperplasia
}

1735 - 1805

Urinary incontinence in women: biofeedback as an innovative treatment method 
}

1805 - 1835

Difficult Cases to Treat
Mohannad Alharbi
}

1835 - 1905

Recent advances in the treatment of erectile dysfunction  
}

1905 - 1935

Interactive Discussion on Urinary obstruction diseases – facilitated by
Mohannad Alharbi
}

1935 - 1940

Closing remarks  
Mohannad Alharbi

Scientific Committee

Our Scientific Committee

Yasser Farahat

Yasser Farahat

Chairman

Mubarak Al-Mansour

Mubarak Al-Mansour

Chairman

Mohannad Alharbi

Mohannad Alharbi

Chairman

Speakers

Our Speakers

Yasser Farahat

Yasser Farahat

Hassan Jaafar

Hassan Jaafar

Shouki Bazarbashi

Shouki Bazarbashi

Abdullah Alsharm

Abdullah Alsharm

Emad Anwar Dawoud

Emad Anwar Dawoud

Mubarak Al-Mansour

Mubarak Al-Mansour

Bertrand Tombal

Bertrand Tombal

Mohannad Alharbi

Mohannad Alharbi

Partners and Supporting bodies:

SoS-logo
SUA logo
eons-logo

CME

Accreditation

THIS CONFERENCE WILL PROVIDE CONTINUING MEDICAL EDUCATION CREDIT POINTS CME credits, provided by Dubai Health Authority (DHA), will be announced 10 working days after the live conference days.

Certificates of Attendance will be emailed to the registered email address, under the registered full name, as a PDF within 10 days after the conclusion of the 30- days on demand, to allow maximum benefit to the participants. Attendance of 75% of the session is mandatory to claim your credit points. Attendance is monitored and recorded, for all live-days and the 30-days on-demand playback.